PubMed Health⌕ Search

Biomedical subjects

P Pantelinac

Publications and source records attributed to P Pantelinac.

7 recordsLinked to original sources
PubMed1996

[The metabolic syndrome and hyper-Lp(a)-lipoproteinemia in peripheral obliterative atherosclerosis: 2 case reports].

One of the characteristics of peripheral vascular disease in diabetic patients is that it occurs at the time of detection of diabetes mellitus. As one of the possible pathogenic mechanisms, in non-smokers, is the sol-called metabolic syndrome (obesity, disorders in regard to metabolism of lipids and carbohydrates and hypertension). Lipoprotein Lp(a) is the most atherogenic among lipoproteins. While data on coronary arterial disease exist, although contradictory, there is a small number of those which document the same for peripheral vascular occlusive disease in diabetics. Two patients, non-smokers, with characteristic constellation of risk factors, are described as possible models for further epidemiologic examinations.

Arteriosclerosis Obliterans↗
PubMed1995

[Acute painful neuropathy--2 case reports].

Diabetic neuropathy, clinically established, occurs in up to 50% of diabetics, sometimes even prior to detection of diabetes mellitus. Distal symmetric polyneuropathy is the most frequent clinically established lesion of the nervous system. Other clinical entities, however, are not so rare, if they are studied with attention using differential diagnostic procedure. In this paper authors present two patients with sub-types of one of the rare forms of diabetic peripheral neuropathy--so called acute painful neuropathy: the first case associated with unregulated diabetes mellitus and in the second patient it occurred as a consequence of abrupt normalization of glycemic control with so-called insulin neuritis. The authors described the most important clinical characteristics of patients, differential diagnosis, therapy and the course of the disease.

Acute Disease↗
PubMedDate not supplied

[Inhibin and its characteristics].

On the basis of data from current literature a survey of the new hormone, inhibin, and its characteristics, is given, particularly with respect to its role in the regulation of fertility. There were also enumerated its other features and possibilities of its use in diagnostical and other practical purposes.

Humans↗